Literature DB >> 21255815

Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.

Jerome Schaack1, Michael L Bennett, Gary S Shapiro, James DeGregori, James L McManaman, John W Moorhead.   

Abstract

E1-deleted adenovirus (FG Ad) transducing vectors are limited for use in vivo by their induction of strong innate and adaptive inflammatory responses. We have examined the contribution of the transgene cassette, particularly the foreign promoter driving transgene expression, in the induction of innate inflammation using a mouse ear model in which swelling is measured as a sensitive surrogate marker of the total innate inflammatory response. The commonly used cytomegalovirus major immediate early (CMV) promoter led to high-level swelling that was independent of transgene expression, while the Rous sarcoma virus and human ubiquitin C promoters led to intermediate levels of swelling and the Ad E1A promoter or no promoter led to equally low levels of swelling. Significant swelling was induced by a virus in which the E1A promoter directed pIX expression, supporting the possibility that activation of expression of Ad genes retained in the vector plays an important role in the inflammatory response. Taken together, our findings support the idea that strong foreign promoters likely play the limiting role in the induction of innate and adaptive immune responses that limit the duration of transgene expression after transduction by FG Ad vectors.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21255815      PMCID: PMC4419336          DOI: 10.1016/j.virol.2010.12.054

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Adenovirus transduction of 3T3-L1 cells.

Authors:  D J Orlicky; J Schaack
Journal:  J Lipid Res       Date:  2001-03       Impact factor: 5.922

2.  Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

Authors:  Y Zhang; N Chirmule; G P Gao; R Qian; M Croyle; B Joshi; J Tazelaar; J M Wilson
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

3.  cis-dominant defect in activation of adenovirus type 5 E1b early RNA synthesis.

Authors:  C L Parks; D J Spector
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products.

Authors:  N Reich; R Pine; D Levy; J E Darnell
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

Authors:  Y Yang; K U Jooss; Q Su; H C Ertl; J M Wilson
Journal:  Gene Ther       Date:  1996-02       Impact factor: 5.250

6.  In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.

Authors:  P R Clemens; S Kochanek; Y Sunada; S Chan; H H Chen; K P Campbell; C T Caskey
Journal:  Gene Ther       Date:  1996-11       Impact factor: 5.250

7.  Local character of readthrough activation in adenovirus type 5 early region 1 transcription control.

Authors:  Li Shen; David J Spector
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission.

Authors:  Drew L Lichtenstein; William S M Wold
Journal:  Cancer Gene Ther       Date:  2004-12       Impact factor: 5.987

9.  A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears.

Authors:  J W Moorhead; G H Clayton; R L Smith; J Schaack
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines.

Authors:  J Schaack; X Guo; W Y Ho; M Karlok; C Chen; D Ornelles
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more
  3 in total

1.  Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellular neurosecretory neurons in the rat supraoptic nucleus.

Authors:  Faye C Doherty; Jerome B Schaack; Celia D Sladek
Journal:  J Neurosci Methods       Date:  2011-03-08       Impact factor: 2.390

Review 2.  Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs.

Authors:  Julio Alonso-Padilla; Tibor Papp; Győző L Kaján; Mária Benkő; Menzo Havenga; Angelique Lemckert; Balázs Harrach; Andrew H Baker
Journal:  Mol Ther       Date:  2015-10-19       Impact factor: 11.454

3.  Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination.

Authors:  Julia M Colston; Beatrice Bolinger; Matthew G Cottingham; Sarah Gilbert; Paul Klenerman
Journal:  J Immunol       Date:  2016-03-04       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.